| Financial Year |
March 31 2023 |
| Monetary Funds |
21,783,903,296.56 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
12,763,285,295.99 |
| Advances to Suppliers |
7,353,157,008.59 |
| Other Receivables |
6,396,109,872.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
41,004,685.22 |
| Dividend Receivable |
305,622.99 |
| Inventories |
15,781,795,381.81 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
28,531,256.24 |
| Other Current Assets |
1,234,521,631.72 |
| Total Current Assets |
95,247,168,560.83 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
638,396,204.45 |
| Investment Properties |
-- |
| Fixed Assetes |
4,847,917,491.39 |
| Under-construction Projects |
44,337,126.59 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,643,076,364.17 |
| R&D expenses |
14,207,382.47 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
120,397,868.25 |
| Deferred Income Tax Assets |
258,366,252.36 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
8,466,579,131.28 |
| Total Assets |
103,713,747,692.11 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
7,087,518,636.47 |
| Accounts Payable |
33,815,332,775.88 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
725,940,470.45 |
| Taxes Payable |
1,165,905,667.12 |
| Interest Payable |
-- |
| Dividend Payable |
4,814,566.98 |
| Other payables |
8,154,232,097.10 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
203,230,841.96 |
| Other Current Liabilities |
2,133,064,811.27 |
| Sub-Total of Current Liabilities |
75,728,539,106.42 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
301,067,099.59 |
| Deferred Income Tax Liabilities |
114,597,709.37 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,238,539,841.18 |
| Total Liabilities |
77,967,078,947.60 |
| Paid-In Capital(Or Share Stock) |
5,583,147,471.00 |
| Capital Surplus |
14,575,742,982.78 |
| Surplus Reserve |
1,256,360,655.69 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,570,437,344.92 |
| Minority Stockholder's Interest |
65,008,831.98 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
25,681,659,912.53 |
| Owner's Equity（Stockholder's Equity） |
25,746,668,744.51 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
103,713,747,692.11 |
